Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Eupraxia Pharmaceuticals (EPRX): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Outperform
8 analysts
Options Flow (P/C)
—
Avg Consensus PT
$17
+104.8%
Highest Price Target
$25
+206.4%
Lowest Price Target
$9
+10.3%
Short Interest
—
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | HC Wainwright & Co. | Brandon Folkes— | +96.1% | $11 → $16 | Maintained | Buy |
| Nov 9, 2026 | RBC Capital | Douglas Miehm— | +71.6% | $14 | Initiate | Outperform |